{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:24:26Z","timestamp":1794936266389,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC0867500"],"award-info":[{"award-number":["2022YFC0867500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.heliyon.2023.e13598","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T07:46:41Z","timestamp":1676015201000},"page":"e13598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin"],"prefix":"10.1016","volume":"9","author":[{"given":"Xi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7462-0622","authenticated-orcid":false,"given":"Zhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10082","key":"10.1016\/j.heliyon.2023.e13598_bib1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e13598_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biopha.2018.05.104","article-title":"Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK\/AP-1 pathways","volume":"105","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13598_bib3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13598_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/jmv.26634","article-title":"Discharge may not be the end of treatment: pay attention to pulmonary fibrosis caused by severe COVID-19","volume":"93","author":"Zhang","year":"2021","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e13598_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5090078","article-title":"Real world experiences: pirfenidone and nintedanib are effective and well tolerated treatments for idiopathic pulmonary fibrosis","volume":"5","author":"Hughes","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.heliyon.2023.e13598_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/PROM.S144425","article-title":"Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives","volume":"9","author":"Graney","year":"2018","journal-title":"Patient Relat. Outcome Meas."},{"issue":"22","key":"10.1016\/j.heliyon.2023.e13598_bib7","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.2018.6225","article-title":"Clinical trials in idiopathic pulmonary fibrosis in the \"posttreatment era","volume":"319","author":"Gibson","year":"2018","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.heliyon.2023.e13598_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","article-title":"The bleomycin model of pulmonary fibrosis","volume":"1627","author":"Liu","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13598_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/17460441.2020.1755252","article-title":"Current models of pulmonary fibrosis for future drug discovery efforts","volume":"15","author":"Yanagihara","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.heliyon.2023.e13598_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fmed.2017.00118","article-title":"Exploring animal models that resemble idiopathic pulmonary fibrosis","volume":"4","author":"Tashiro","year":"2017","journal-title":"Front. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13598_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.heliyon.2023.e13598_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110058","article-title":"Ophiocordyceps lanpingensis polysaccharides attenuate pulmonary fibrosis in mice","volume":"126","author":"Zhou","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e13598_bib13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fphar.2019.01021","article-title":"Antifibrotic mechanism of cinobufagin in bleomycin-induced pulmonary fibrosis in mice","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e13598_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172712","article-title":"Neohesperidin inhibits TGF-beta1\/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice","volume":"864","author":"Guo","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e13598_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","article-title":"An official American thoracic society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis","volume":"56","author":"Jenkins","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13598_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/RLI.0b013e31816900ec","article-title":"Semiquantitative measurement of murine bleomycin-induced lung fibrosis in in vivo and postmortem conditions using microcomputed tomography: correlation with pathologic scores - initial results","volume":"43","author":"Lee","year":"2008","journal-title":"Invest. Radiol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13598_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.heliyon.2023.e13598_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40248-017-0089-0","article-title":"Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice","volume":"12","author":"Ruscitti","year":"2017","journal-title":"Multidisc. Res. Med."},{"key":"10.1016\/j.heliyon.2023.e13598_bib19","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3389\/fphar.2020.01117","article-title":"Quantification of lung fibrosis in IPF-like mouse model and pharmacological response to treatment by micro-computed tomography","volume":"11","author":"Ruscitti","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13598_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71293-3","article-title":"In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach","volume":"10","author":"Mecozzi","year":"2020","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e13598_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/thoraxjnl-2016-208423","article-title":"Pulmonary CCR2(+)CD4(+) T cells are immune regulatory and attenuate lung fibrosis development","volume":"72","author":"Milger","year":"2017","journal-title":"Thorax"},{"issue":"10 Pt 1","key":"10.1016\/j.heliyon.2023.e13598_bib22","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1164\/ajrccm.164.10.2104013","article-title":"Cytokine balance in the lungs of patients with acute respiratory distress syndrome","volume":"164","author":"Park","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3 Pt 1","key":"10.1016\/j.heliyon.2023.e13598_bib23","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1164\/ajrccm.162.3.9906007","article-title":"Increased levels of interleukin-6 are associated with lymphocytosis in bronchoalveolar lavage fluids of idiopathic nonspecific interstitial pneumonia","volume":"162","author":"Park","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8B","key":"10.1016\/j.heliyon.2023.e13598_bib24","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1582-4934.2008.00647.x","article-title":"TNF-\u03b1 induces TGF-\u03b21 expression in lung fibroblasts at the transcriptional level via AP-1 activation","volume":"13","author":"Sullivan","year":"2009","journal-title":"J. Cell Mol. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13598_bib25","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2222.2004.02013.x","article-title":"Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen","volume":"34","author":"Qiu","year":"2010","journal-title":"Clin. Exp. Allergy"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13598_bib26","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1164\/ajrccm.163.6.2006064","article-title":"Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis","volume":"163","author":"Pantelidis","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13598_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/1060028020964451","article-title":"Systematic review and meta-analysis of pirfenidone, nintedanib, and pamrevlumab for the treatment of idiopathic pulmonary fibrosis","volume":"55","author":"Di Martino","year":"2021","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13598_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1444-0903.2004.00503.x","article-title":"Cytokine gene polymorphisms in idiopathic pulmonary fibrosis","volume":"34","author":"Riha","year":"2004","journal-title":"Intern. Med. J."},{"issue":"2 Pt 1","key":"10.1016\/j.heliyon.2023.e13598_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1164\/ajrccm.162.2.9909053","article-title":"Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms","volume":"162","author":"Whyte","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13598_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-9440(10)65624-6","article-title":"Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts","volume":"153","author":"Sime","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13598_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1165\/ajrcmb.25.1.4481","article-title":"Transforming growth factor-beta(1) overexpression in tumor necrosis factor-alpha receptor knockout mice induces fibroproliferative lung disease","volume":"25","author":"Liu","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13598_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/01902149209020649","article-title":"Lung cytokine production in bleomycin-induced pulmonary fibrosis","volume":"18","author":"Phan","year":"1992","journal-title":"Exp. Lung Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13598_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1183\/09031936.94.07030515","article-title":"Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice","volume":"7","author":"Piguet","year":"1994","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e13598_bib34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2007-0299OC","article-title":"Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice","volume":"38","author":"Saito","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13598_bib35","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.3892\/mmr.2017.7036","article-title":"IL?6\/STAT3\/miR?34a protects against neonatal lung injury patients","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2023.e13598_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8539294","article-title":"The expression of IL-6, TNF-alpha, and MCP-1 in respiratory viral infection in acute exacerbations of chronic obstructive pulmonary disease","volume":"2017","author":"Zheng","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13598_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1165\/rcmb.2016-0121TR","article-title":"Immune mechanisms in pulmonary fibrosis","volume":"55","author":"Kolahian","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2023.e13598_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-9255-4-14","article-title":"CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis","volume":"4","author":"Papiris","year":"2007","journal-title":"J. Inflamm."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13598_bib39","doi-asserted-by":"crossref","first-page":"L92","DOI":"10.1152\/ajplung.2001.281.1.L92","article-title":"IL-12 attenuates bleomycin-induced pulmonary fibrosis","volume":"281","author":"Keane","year":"2001","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13598_bib40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2353\/ajpath.2006.051160","article-title":"Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis","volume":"169","author":"Kimura","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13598_bib41","doi-asserted-by":"crossref","first-page":"L658","DOI":"10.1152\/ajplung.00006.2006","article-title":"Increased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet","volume":"291","author":"Xu","year":"2006","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13598_bib42","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3348\/kjr.2020.0215","article-title":"Prediction of the development of pulmonary fibrosis using serial thin-section CT and clinical features in patients discharged after treatment for COVID-19 pneumonia","volume":"21","author":"Yu","year":"2020","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.heliyon.2023.e13598_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2019.121566","article-title":"Short-term PM2.5 exposure induces sustained pulmonary fibrosis development during post-exposure period in rats","volume":"385","author":"Sun","year":"2020","journal-title":"J. Hazard Mater."}],"updated-by":[{"DOI":"10.1016\/j.heliyon.2025.e43382","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000}}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023008058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023008058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:08:59Z","timestamp":1776215339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023008058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2405844023008058"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13598","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e13598"}}